Sfoglia per Rivista VACCINES
The impact of serotype cross-protection on vaccine trials: Denvax as a case study
2020-01-01 Aguiar, Maira; Stollenwerk, N.
Real-World Evidence in Cost-Effectiveness Analysis of Enhanced Influenza Vaccines in Adults ≥ 65 Years of Age: Literature Review and Expert Opinion
2023-01-01 Postma, Maarten; Fisman, David; Giglio, Norberto; Márquez-Peláez, Sergio; Nguyen, Van Hung; Pugliese, Andrea; Ruiz-Aragón, Jesús; Urueña, Analia; Mould-Quevedo, Joaquin
Titolo | Anno di pubblicazione | Autori Unitn | File |
---|---|---|---|
The impact of serotype cross-protection on vaccine trials: Denvax as a case study | 1-gen-2020 | Aguiar MairaStollenwerk N. | |
Real-World Evidence in Cost-Effectiveness Analysis of Enhanced Influenza Vaccines in Adults ≥ 65 Years of Age: Literature Review and Expert Opinion | 1-gen-2023 | Pugliese, Andrea + |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile